Investigational malaria vaccine gives strong, lasting protection
Phase 1 trials conducted at NIH Clinical Center.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: American Health | Malaria | Malaria Vaccine | National Institutes of Health (NIH) | Vaccines